Velcade®

DRUG2 trials

Sponsors

Oncology Specialists, S.C., Nantes University Hospital

Conditions

Lymphoma, B-CellLymphoma, Non-HodgkinMultiple Myeloma

Phase 2

VELCADE,Rituximab,Cyclophosphamide and Decadron

TerminatedNCT00413959

Oncology Specialists, S.C.Lymphoma, B-Cell, Lymphoma, Non-Hodgkin

Start: 2006-08-31End: 2011-01-31Updated: 2018-09-19

Phase 3

Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

CompletedNCT01971658

Nantes University HospitalMultiple Myeloma

Start: 2013-10-31End: 2015-08-31Updated: 2015-10-07

Related Papers

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma

Frontiers in Oncology2023-11-0216 citations